Bachir Latli, Matt J. Hrapchak, Maxim Chevliakov, Lalith P. Samankumara, Rogelio P. Frutos, Heewon Lee
{"title":"甘氨酸转运蛋白1抑制剂Iclepertin(BI 425809)及其主要代谢产物的稳定同位素合成。","authors":"Bachir Latli, Matt J. Hrapchak, Maxim Chevliakov, Lalith P. Samankumara, Rogelio P. Frutos, Heewon Lee","doi":"10.1002/jlcr.4063","DOIUrl":null,"url":null,"abstract":"<p>Stable isotope labeled <b>Iclepertin (BI 425809, 1)</b> and its major metabolites are needed as internal standards in bioanalytical studies. <b>BI 425809</b> consists of two main building blocks, 5-methylsulfonyl-2-[(1<i>R</i>)-2,2,2-trifluoro-1-methyl-ethoxy]benzoic acid (<b>2</b>) and 3-[(1<i>R</i>,5<i>R</i>)-3-azabicyclo[3.1.0]hexan-5-yl]-5-(trifluoromethyl)isoxazole (<b>3</b>) linked to each other via an amide bond. We used fluoro[<sup>13</sup>C<sub>6</sub>]benzene as the starting material in the preparation of <b>[</b><sup><b>13</b></sup><b>C</b><sub><b>6</b></sub><b>]-2</b>. This intermediate was then employed to access carbon 13 labeled <b>Iclepertin</b> (<b>[</b><sup><b>13</b></sup><b>C</b><sub><b>6</b></sub><b>]-1</b>) and other metabolites. The major metabolite <b>BI 761036</b> (<b>6</b>), which resulted from cytochrome P450 oxidation and amide hydrolysis of <b>BI 425809</b>, was prepared labeled with carbon 13 and nitrogen 15 via two synthetic routes. In the first route, diethyl [<sup>13</sup>C<sub>3</sub>]malonate, [<sup>13</sup>C]methyl iodide, and hydroxyl[<sup>15</sup>N]amine were used to provide <b>[</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-BI 761036 ([</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-6a)</b> in 13 steps in 6% overall yield, whereas in the second route, [<sup>13</sup>C<sub>3</sub>]propargyl alcohol, potassium [<sup>13</sup>C]cyanide, and [<sup>15</sup>N]ammonia were used to furnish <b>[</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-BI 761036 ([</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-6b)</b> in 11 steps in 1% overall yield. The detailed stable isotope synthesis of <b>1</b> and its major metabolites is described.</p>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"66 13","pages":"414-427"},"PeriodicalIF":0.9000,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Stable isotope synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites\",\"authors\":\"Bachir Latli, Matt J. Hrapchak, Maxim Chevliakov, Lalith P. Samankumara, Rogelio P. Frutos, Heewon Lee\",\"doi\":\"10.1002/jlcr.4063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Stable isotope labeled <b>Iclepertin (BI 425809, 1)</b> and its major metabolites are needed as internal standards in bioanalytical studies. <b>BI 425809</b> consists of two main building blocks, 5-methylsulfonyl-2-[(1<i>R</i>)-2,2,2-trifluoro-1-methyl-ethoxy]benzoic acid (<b>2</b>) and 3-[(1<i>R</i>,5<i>R</i>)-3-azabicyclo[3.1.0]hexan-5-yl]-5-(trifluoromethyl)isoxazole (<b>3</b>) linked to each other via an amide bond. We used fluoro[<sup>13</sup>C<sub>6</sub>]benzene as the starting material in the preparation of <b>[</b><sup><b>13</b></sup><b>C</b><sub><b>6</b></sub><b>]-2</b>. This intermediate was then employed to access carbon 13 labeled <b>Iclepertin</b> (<b>[</b><sup><b>13</b></sup><b>C</b><sub><b>6</b></sub><b>]-1</b>) and other metabolites. The major metabolite <b>BI 761036</b> (<b>6</b>), which resulted from cytochrome P450 oxidation and amide hydrolysis of <b>BI 425809</b>, was prepared labeled with carbon 13 and nitrogen 15 via two synthetic routes. In the first route, diethyl [<sup>13</sup>C<sub>3</sub>]malonate, [<sup>13</sup>C]methyl iodide, and hydroxyl[<sup>15</sup>N]amine were used to provide <b>[</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-BI 761036 ([</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-6a)</b> in 13 steps in 6% overall yield, whereas in the second route, [<sup>13</sup>C<sub>3</sub>]propargyl alcohol, potassium [<sup>13</sup>C]cyanide, and [<sup>15</sup>N]ammonia were used to furnish <b>[</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-BI 761036 ([</b><sup><b>13</b></sup><b>C</b><sub><b>4</b></sub>,<sup><b>15</b></sup><b>N]-6b)</b> in 11 steps in 1% overall yield. The detailed stable isotope synthesis of <b>1</b> and its major metabolites is described.</p>\",\"PeriodicalId\":16288,\"journal\":{\"name\":\"Journal of labelled compounds & radiopharmaceuticals\",\"volume\":\"66 13\",\"pages\":\"414-427\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of labelled compounds & radiopharmaceuticals\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.4063\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.4063","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
Stable isotope synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites
Stable isotope labeled Iclepertin (BI 425809, 1) and its major metabolites are needed as internal standards in bioanalytical studies. BI 425809 consists of two main building blocks, 5-methylsulfonyl-2-[(1R)-2,2,2-trifluoro-1-methyl-ethoxy]benzoic acid (2) and 3-[(1R,5R)-3-azabicyclo[3.1.0]hexan-5-yl]-5-(trifluoromethyl)isoxazole (3) linked to each other via an amide bond. We used fluoro[13C6]benzene as the starting material in the preparation of [13C6]-2. This intermediate was then employed to access carbon 13 labeled Iclepertin ([13C6]-1) and other metabolites. The major metabolite BI 761036 (6), which resulted from cytochrome P450 oxidation and amide hydrolysis of BI 425809, was prepared labeled with carbon 13 and nitrogen 15 via two synthetic routes. In the first route, diethyl [13C3]malonate, [13C]methyl iodide, and hydroxyl[15N]amine were used to provide [13C4,15N]-BI 761036 ([13C4,15N]-6a) in 13 steps in 6% overall yield, whereas in the second route, [13C3]propargyl alcohol, potassium [13C]cyanide, and [15N]ammonia were used to furnish [13C4,15N]-BI 761036 ([13C4,15N]-6b) in 11 steps in 1% overall yield. The detailed stable isotope synthesis of 1 and its major metabolites is described.
期刊介绍:
The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo.
The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.